changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
The emerging area of interventional Pulmonology is dedicated to improving the lung function, exercise capacity and quality of life for patients with degraded lung function including emphysema5.
For over 10 years we have been focused on developing minimally-invasive medical devices for pulmonary diseases such as emphysema. We have a commercial available product in Europe to treat both heterogeneous and homogeneous emphysema.
The product is not approved for commercial sale in the US, and is restricted by law to investigational use only in the US.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com